Holen Sie sich die Stockscreener-App
1.33
3.10%
0.04
Handel nachbörslich:
1.35
0.02
+1.50%
Schlusskurs vom Vortag:
$1.29
Offen:
$1.29
24-Stunden-Volumen:
141.11K
Relative Volume:
0.70
Marktkapitalisierung:
$169.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-12.84M
KGV:
-11.64
EPS:
-0.1143
Netto-Cashflow:
$-8.76M
1W Leistung:
+4.72%
1M Leistung:
+9.02%
6M Leistung:
-36.97%
1J Leistung:
+64.20%
1-Tages-Spanne:
$1.27
$1.35
1-Wochen-Bereich:
$1.14
$1.35
52-Wochen-Spanne:
$0.7601
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Firmenname
Tiziana Life Sciences Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare TLSA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
1.33 | 164.15M | 0 | -12.84M | -8.76M | -0.1143 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
| 2018-12-17 | Eingeleitet | Laidlaw | Buy |
Tiziana Life Sciences Ltd Aktie (TLSA) Neueste Nachrichten
Market movers: Tesla, Wells Fargo, Lucid Group, Tiziana Life Sciences, Trillion Energy… - Proactive financial news
Tiziana Life Sciences’ Intranasal Foralumab MSA Trial Highlighted in Late-Breaking Poster at 7th World Parkinson Congress - TipRanks
Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress - The Manila Times
Tiziana Life Sciences (TLSA) highlights Phase 2a intranasal foralumab MSA trial at World Parkinson Congress - Stock Titan
Tiziana Life Sciences to present Phase 2a MSA study at World Parkinson Congress - Proactive financial news
Aug Setups: What is the Moat Score of BlackRock Virginia Municipal Bond Trust2026 Pullback Review & Stock Timing and Entry Methods - baoquankhu1.vn
Swing Trade: Can Tiziana Life Sciences Ltd maintain its current growth ratePortfolio Gains Report & Consistent Return Investment Signals - baoquankhu1.vn
Downgrade Watch: Is Tiziana Life Sciences Ltd a cyclical or defensive stockMarket Risk Analysis & Reliable Entry Point Alerts - baoquankhu1.vn
TLSA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Tiziana Life Sciences (NASDAQ:TLSA) Trading 6.8% HigherHere's What Happened - MarketBeat
Market movers: Nike, RH, Tiziana Life Sciences, Eli Lilly… - Proactive financial news
Tiziana Life Sciences Stock Jumps As Positive Preclinical Fuels Momentum - Benzinga
Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging - Bitget
Tiziana Life Sciences reports positive preclinical findings for intranasal anti-CD3 therapy in brain aging - Proactive financial news
Tiziana Life Sciences Reports Positive Preclinical Data for Nasal Anti-CD3 in Age-Related Cognitive Decline - TipRanks
Tiziana Life Sciences (NASDAQ: TLSA) posts positive nasal anti-CD3 data in aging model - Stock Titan
Tiziana Life Sciences Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging - marketscreener.com
Volume Report: What are the future prospects of Tiziana Life Sciences LtdInflation Watch & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Update Report: Does Tiziana Life Sciences Ltd outperform in volatile marketsQuarterly Trade Report & Risk Managed Investment Signals - baoquankhu1.vn
Aug Outlook: Does Tiziana Life Sciences Ltd offer margin of safety2026 Chart Watch & Safe Capital Allocation Plans - baoquankhu1.vn
If You Invested $1,000 in Tiziana Life Sciences Ltd Com (TLSA) - Stock Titan
Tiziana Life Sciences Ltd: Fundamental Analysis and Financial Ratings | 0RP | BMG889121031 - marketscreener.com
Macro Review: Is Tiziana Life Sciences Ltd stock a good dividend stock2026 Retail Activity & Verified Swing Trading Watchlists - baoquankhu1.vn
Large TLSA stake reported by director Gabriele M. Cerrone on Form 3 - Stock Titan
Macro Review: Is Tiziana Life Sciences Ltd subject to activist investor interest2026 Closing Moves & Weekly Sector Rotation Insights - baoquankhu1.vn
Forecast Cut: Can Tiziana Life Sciences Ltd maintain its current growth rate2026 Big Picture & Fast Moving Stock Watchlists - baoquankhu1.vn
Price Action: Can Tiziana Life Sciences Ltd be recession proofTrade Risk Report & High Accuracy Investment Signals - baoquankhu1.vn
TLSA Earnings History & Surprises | EPS & Revenue Results | TIZIANA LIFE SCIENCES LTD (NASDAQ:TLSA) - ChartMill
Tiziana Life Sciences (NASDAQ:TLSA) Stock Price Down 4.4%Should You Sell? - MarketBeat
Tiziana Life Sciences (TLSA) Stock Analysis Report | Financials & Insights - Benzinga Japan
Whats next for Tiziana Life Sciences Ltd stockAnalyst Upgrade & Real-Time Volume Trigger Notifications - baoquankhu1.vn
New Highs: Can Tiziana Life Sciences Ltd expand its profit margins2026 Sector Moves & Fast Gaining Stock Reports - baoquankhu1.vn
Aug Macro: Is Tiziana Life Sciences Ltd a stock for growth or value investorsMarket Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Day Trade: Can Tiziana Life Sciences Ltd maintain its current growth rate2025 Volume Leaders & Momentum Based Trading Ideas - baoquankhu1.vn
Market movers: Circle Internet Group, Tiziana Life Sciences, Cava, Lowe’s… - Proactive Investors
Tiziana reports biomarker gains for nasal MS therapy in progressive disease - Yahoo
Tiziana Life Sciences PLC (TLSA) announces new biomarker data - Bitget
Tiziana Life Sciences Posts Positive Biomarker Data for Intranasal Foralumab in Progressive MS - TipRanks
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA - The Manila Times
New foralumab biomarker data in na-SPMS from Tiziana (Nasdaq: TLSA) - Stock Titan
Tiziana Life Sciences Ltd. - Via Ritzau
What’s next for Tiziana Life Sciences Ltd stockIndex Update & Safe Capital Growth Stock Tips - mfd.ru
Tiziana Life Sciences (NASDAQ:TLSA) Trading Up 0.7%Here's What Happened - MarketBeat
Does Tiziana Life Sciences Ltd outperform in volatile markets2025 Growth vs Value & Short-Term Trading Alerts - mfd.ru
What is Tiziana Life Sciences Ltd s 5 year growth outlookM&A Rumor & Smart Allocation Stock Reports - mfd.ru
TLSA PE Ratio & Valuation, Is TLSA Overvalued - Intellectia AI
TLSA Should I Buy - Intellectia AI
Is Tiziana Life Sciences Ltd stock affected by interest rate hikesPortfolio Value Report & Risk Adjusted Buy and Sell Alerts - mfd.ru
How Tiziana Life Sciences Ltd stock reacts to Fed rate cutsWeekly Trading Summary & Free Expert Verified Stock Movement Alerts - mfd.ru
Is Tiziana Life Sciences Ltd in a consolidation phaseEarnings Miss & Weekly High Potential Stock Alerts - mfd.ru
Can Tiziana Life Sciences Ltd sustain earnings growth2025 Trade Ideas & Safe Capital Growth Stock Tips - mfd.ru
Finanzdaten der Tiziana Life Sciences Ltd-Aktie (TLSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):